Advanced gastric cancer: Is laparoscopic gastrectomy safe?

Surgical Endoscopy

Volumn 23, Issue 5, 2009, Pages 1161-1163

  Liakakos, T ^a   Misiakos, E P ^a   MacHeras, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADVANCED CANCER; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; GASTRECTOMY; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LAPAROSCOPIC SURGERY; LETTER; LYMPHADENECTOMY; OPEN DISTAL GASTRECTOMY; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH CANCER; SURGICAL TECHNIQUE;

EID: 67349116827     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0427-1     Document Type: Letter

References (36)

1. KW Ryu YW Kim JH Lee 2008 Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer Ann Surg Oncol 15 1625 1631
2. Hwang SI, Kim HO, Yoo CH, Shin JH, Son BH (2008) Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer. Surg Endosc. Epub ahead of print
3. D Ziogas D Roukos 2008 Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22 5 1405 1406
4. JH Lee YW Kim KW Ryu 2007 A phase II clinical trial of laparoscopy-assisted distal gastrectomy with d2 lymph node dissection for gastric cancer patients Ann Surg Oncol 14 3148 3153 (Pubitemid 47594269)
5. The Japan Clinical Oncology Group M Sasako T Sano S Yamamoto 2008 D2 lymphadenectomy alone or with paraaortic nodal dissection for gastric cancer N Engl J Med 359 453 462
6. S Sakuramoto M Sasako T Yamaguchi 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 (Pubitemid 350044801)
7. T Liakakos DH Roukos 2008 More controversy than ever: challenges and promises towards personalized treatment of gastric cancer Ann Surg Oncol 15 956 960
8. DH Roukos 2004 Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127 129 (Pubitemid 40486786)
9. AM Kappas DH Roukos 2002 Quality of surgery determinant for the outcome of patient with gastric cancer Ann Surg Oncol 9 828 830 (Pubitemid 35265631)
10. DH Roukos M Lorenz A Encke 1998 Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study Surgery 123 573 578 (Pubitemid 28215371)
11. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 2695 (Pubitemid 47460616)
12. DH Roukos 2002 Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9 220 221 (Pubitemid 34298624)
13. E Briasoulis T Liakakos L Dova 2006 Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931 939 (Pubitemid 44201562)
14. RS Punglia M Morrow EP Winer 2007 Local therapy and survival in breast cancer N Engl J Med 356 2399 2440 (Pubitemid 46887273)
15. DH Roukos AM Kappas NJ Agnantis 2003 Perspectives and risks of breast conservation therapy for breast cancer Ann Surg Oncol 10 718 721 (Pubitemid 40486870)
16. M Fatouros DH Roukos I Arampatzis A Sotiriadis E Paraskevaidis AM Kappas 2005 Factors increasing local recurrence in breast-conserving surgery Expert Rev Anticancer Ther 5 737 745 (Pubitemid 41223280)
17. DH Roukos 2008 Linking contralateral breast cancer with genetics Radiother Oncol 86 139 141
18. DC Chung SS Yoon GY Lauwers D Patel 2007 Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer N Engl J Med 357 283 291
19. D Ziogas G Baltogiannis M Fatouros DH Roukos 2008 Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations Ann Surg 247 714 715
20. DH Roukos 2007 Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 1555 1556 author reply 1556 (Pubitemid 47572649)
21. M Fatouros G Baltoyiannis DH Roukos 2008 The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations Ann Surg Oncol 15 21 33
22. DH Roukos NJ Agnanti E Paraskevaidis AM Kappas 2002 Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations Ann Surg Oncol 9 941 943 (Pubitemid 35424626)
23. NJ Agnantis E Paraskevaidis D Roukos 2004 Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance Ann Surg Oncol 11 1030 1034 (Pubitemid 40486647)
24. TA Manolio LD Brooks FS Collins 2008 A HapMap harvest of insights into the genetics of common disease J Clin Invest 18 1590 1605
25. DH Roukos 2008 Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery Expert Rev Mol Diagn 8 587 597
26. DH Roukos E Lykoudis T Liakakos 2008 Genomics and challenges toward personalized breast cancer local control J Clin Oncol 26 4360 4361
27. DH Roukos 2008 Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies Expert Rev Mol Diagn 8 29 39
28. CC Huang M Bredel 2008 Use of gene signatures to improve risk estimation in cancer JAMA 299 1605 1606
29. DH Roukos 2008 HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 358 197 198
30. DH Roukos 2008 Breast cancer stromal cells with TP53 mutations N Engl J Med 358 1636
31. M Esteller 2008 Epigenetics in cancer N Engl J Med 358 1148 1159
32. DH Roukos 2009 Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention Expert Rev Mol Diagn 9 1 1 6
33. DH Roukos 2009 Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer Ann Surg Oncol 16 4 795 798
34. DH Roukos 2009 Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer J Clin Oncol 27 8 1337 1338
35. DH Roukos 2009 Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine Ann Surg Oncol 16 3 772 773
36. DH Roukos D Ziogas 2009 Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian Knot"? Ann Surg Oncol 16 3 774 775